Use of Hepatitis B Core Antibody–Positive Liver Allograft in Hepatitis C Virus–Positive and –Negative Recipients With Use of Short Course of Hepatitis B Immunoglobulin and Lamivudine

This publication has 6 references indexed in Scilit:

• IMPACT OF HEPATITIS C VIRAL INFECTION IN PRIMARY CADAVERIC LIVER ALLOGRAFT VERSUS PRIMARY LIVING-DONOR ALLOGRAFT IN 100 CONSECUTIVE LIVER TRANSPLANT RECIPIENTS RECEIVING TACROLIMUS
  Transplantation, 2004
• Use of hepatitis B core antibody-positive donors in recipients without evidence of hepatitis B infection: A survey of current practice in the United States
  Liver Transplantation, 2003
• PREVENTION OF DE NOVO HEPATITIS B INFECTION IN RECIPIENTS OF HEPATIC ALLOGRAFTS FROM ANTI-HBc POSITIVE DONORS
  Transplantation, 1999
• INFECTIVITY OF HEPATIC ALLOGRAFTS WITH ANTIBODIES TO HEPATITIS B VIRUS
  Transplantation, 1997
• Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database
  Gastroenterology, 1997
• The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient
  Liver Transplantation and Surgery, 1997